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INTRODUCTION
Actinomycetoma is one of the most neglected of 
diseases. It is caused by aerobic actinomycete bacte-
ria via a localized trauma of the skin. Actinomadura 
madurae is best known worldwide as the cause of acti-
nomycotic mycetomas (F a h a l , 2004). Mycetoma 
is a chronic specific granulomatous subcutaneous 
inflammatory disease that is produced by various 
causative agents that can be either true fungi or 
aerobic actinomycetes of the genera Actinomadura, 
Nocardia, and Streptomyces (A h m e d  et al., 2004). 
Actinomadura spp. commonly occur in some coun-
tries and can produce as much as 50% of the total 
cases of mycetoma (We l s h , 1991). The majority of 
reports of infections by this species are from tropi-
cal and subtropical countries. It has been reported 
that A. madurae can be treated with several drugs: 
amikacin, amoxicillin-clavulanate, cefotaxime, cef-
triaxone, doxycycline, imipenem, minocycline, sul-
famethoxazole, trimethoprim-sulfamethoxazole, 
ampicillin, ciprofloxacin, erythromycin, and strep-
tomycin (We l s h , 1991; M c N e i l  et al., 1990). 
Effective chemotherapy may be complicated by 
adverse drug reactions, antimicrobial resistance, 
and a lack of effective antimicrobial agents. Some of 
these drugs have to be taken for a long period, and in 
some patients they can produce serious side effects, 
such as ototoxicity or nephrotoxicity in treatment 
with amikacin; and hemolytic and aplastic anemia, 
urticaria, and photosensitivity in treatment with sul-
fonamides (M c N e i l  et al., 1990). The discovery of 
lead compounds with the potential to become usable 
drugs in treating diseases caused by A. madurae is 
therefore of prime importance.  
Pinus pinaster Aiton (Maritime Pine) is a mem-
ber of the family Pinaceae. Its oleoresin, known as 
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turpentine, consists of the resin colophonium and 
turpentine oil. Turpentine oil is mainly composed 
of mono-and sesquiterpene hydrocarbons and has 
been of very limited pharmaceutical use in recent 
years. A substantial part of its world production is 
mainly used in the perfume and fragrance indus-
try. Nevertheless, traditional therapeutic and phar-
maceutical uses of its oils are recorded all around 
the world (S c h a u e n b e r g  and P a r i s , 1977). 
The objectives of this study were to determine the 
chemical composition of Pinus pinaster turpentine 
oil from Greece and investigate the antimicrobial 
effects of the obtained oil. Special consideration was 
given to the antimicrobial action of its main bicyclic 
monterpene, α-pinene, on three clinical isolates of 
Actinomadura madurae using an in vitro method. 
MATERIAL AND METHODS
Isolation of the turpentine oil
Turpentine oil was isolated from crude oleoresin of 
Pinus pinaster Aiton (originating from the Greek 
peninsula of Halkidiki) by hydrodistillation in a 
Clevenger-type apparatus for 3 h according to pro-
cedure I as described in Yugoslav Pharmacopoeia 
IV (1984). The obtained turpentine oil was stored 
at +4°C. 
Chemical analyses
Qualitative and quantitative analyses of the tur-
pentine oil were performed using GC and GC/MS. 
The GC analysis of the oil was carried out on a GC 
HP-5890 II apparatus equipped with a split-splitless 
injector attached to a HP-5 column (25 m × 0.32 
mm, 0.52 µm film thickness) and fitted to FID. The 
carrier gas was H2 (1 mL/min). A measured volume 
(1 µL) of sample solution in ethanol (0.2%) was 
injected in split mode (1:30) at 250°C. 
The detector temperature was 300°C (FID), while 
column temperature was linearly programmed from 
40 to 260°C at a rate of 4°C/min. For GC/MS analysis, 
a Hewlett-Packard G 1800C Series II GCD instru-
ment and a HP-5MS column (30 m × 0.25 mm × 0.25 
µm) were used. Mass spectra were recorded in an EI 
regime (70 eV) in a m/z range 40-400. The transfer 
line was heated at 260°C. Identification of the indi-
vidual turpentine oil components was accomplished 
by comparison of retention times with standard 
substances and by matching mass spectral data with 
MS libraries (A d a m s , NIST and Wiley 275.l) using 
a computer search and literature (Adams, 2007). 
For this purpose, quantitative analysis areapercents 
obtained by FID were used as the base. Quantitative 
analysis for area percent obtained by FID was achieved 
by computer search and literature review. 
In order to investigate the potential activity of 
α-pinene, we used a commercial sample of the men-
tioned compound from Sigma-Aldrich, Belgium 
(Catalog number 26, 807-0). 
Bioassays
Three Sudanese clinical isolates of Actinomadura 
madurae were used for bioassays. Actinomadura 
madura strains were directly isolated from patients 
at the Mycetoma Research Center, University of 
Khartoum, Khartoum, Sudan. The cultures were 
grown on Mueller-Hinton agar (MH), stored at 
+4°C, and subcultured once a month. 
Microdilution method
In order to investigate the antimicrobial activity of 
the isolated turpentine oil and α-pinene, a modified 
version of the microdilution technique was used 
(H a n e l  and R a e t h e r , 1988; D a o u k  et al., 1995; 
S o k o v i ć  et al., 2000). Actinomadura madurae 
isolates were cultured at 37ºC in TSB medium for 5 
days. The cell suspension was adjusted with sterile 
saline to a concentration of approximately 1.0 x 105 
in a final volume of 100 µL per well. The inocula 
were stored at +4°C for further use. Dilutions of 
the inocula were cultured on solid MH to verify the 
absence of contamination and check the validity of 
the inoculum. Determination of minimum inhibi-
tory concentrations (MICs) was performed by a 
serial dilution technique using 96-well microtiter 
plates. The investigated turpentine oil was added 
to tryptic soy broth (TSB) medium with the inocu-
lum. Microplates were incubated for 72 h at 37°C. 
The lowest concentrations without visible growth 
(under a binocular microscope) were defined as the 
MICs. The minimum microbicidal concentrations 
(MMCs) were determined by serial subcultivation 
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Table 1.Chemical composition of Pinus pinaster turpentine oil. Abbreviations: *KIE: RRI experimentally determined (calibrated 
AMDIS), **KIL: RRI literature values (Adams, 2007).
Compound Content ( %) KIE* KIL**
trycyclene 0.27 914.0 921
α-pinene 90.82 931.9 932
camphene 0.84 947.0 946
thuja-2,4(10)-diene 0.05 953.3 953
β-pinene 0.64 974.4 974
myrcene 0.40 990.6 988
δ3-carene 0.04 1007.5 1008
p-cymene 0.03 1021.5 1020
limonene 1.03 1025.4 1024
α-pinene oxide 0.59 1092.5 1099
α-fenchocamphoron 0.28 1101.5 1104
trans-pinocarveol 0.14 1132.4 1135
trans-verbenol 0.38 1140.2 1140
pinocarvone 0.12 1155.7 1160
α-terpineol 0.22 1184.9 1186
estragol 0.19 1191.5 1195
verbenone 0.15 1202.9 1204
trans-verbenyl acetate 0.03 1287.5 1291
trans-pinocarvyl acetate 1.18 1293.5 1298
cis-pinocarvyl acetate 0.80 1309.6 1311
myrtenyl acetate 0.15 1316.6 1324
cyclosativene 0.07 1357.2 1369
α-copaene 0.16 1366.4 1374
trans-caryophyllene 0.69 1409.0 1417
α-humulene 0.12 1443.0 1452
α-muurolene 0.25 1493.2 1500
caryophyllene oxide 0.37 1571.1 1582
Total 100
of a 2 µL on microtiter plates containing 100 µL 
of broth per well and further incubation for 72 h 
at 37°C. The lowest concentration with no visible 
growth was defined as the MMC, indicating 99.5% 
killing of the original inoculum. Each experiment 
was repeated in triplicate. Streptomycin was used as 
a positive control (0.1-2 mg·mL-1). 
Statistical analyses
The results of antimicrobial activity were analyzed 
by two-factorial analysis of variance (ANOVA). The 
Statistica Package program (version 4.5, Copyright 
StatSoft, Inc., 1993) was used for statistical evalua-
tion. Experiments were replicated twice under the 
same conditions. All analyses were run in triplicate 
for each replicate (n = 2 × 3). 
RESULTS AND DISCUSSION
The yield of turpentine oil in P. pinaster oleoresin 
was 23.6% (v/m). Gas chromatographic analysis 
(GC and GC/MS) showed a total of 27 mono- and 
sesquiterpenes, representing 100.0% of the oil. The 
principal compound was the bicyclic monoterpene, 
α-pinene (90.82%). Other compounds were present 
in less than 1%, except limonene with 1.03% and 
trans-pinocarvyl acetate with 1.18% (Table 1). 
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Effects of P. pinaster turpentine oil against A. 
madura clinical isolates are presented in Table 2. 
Minimum inhibitory concentrations (MICs) of the 
oil were in range of 100.3 µL/mL – 124.8 µL/mL, 
and minimum microbicidal concentrations (MMCs) 
ranged between 100.3 µL/mL – 150.0 µL/mL. As for 
activity of the compound α-pinene, MICs (from 3.3 
µL/mL to 5.0 µL/mL) and MMCs (10.0 µL/mL) were 
much lower than values obtained for turpentine oil 
and streptomycin. Although P. pinaster turpentine 
oil contains a high concentration of α-pinene, there 
are considerable differences in activity, which could 
be attributable to antagonistic effects of the com-
pounds present in the turpentine oil and/or to cell 
membrane selectivity of this microorganism. 
Voluminous literature exists regarding the 
antimicrobial activity of volatile oils in general 
(D o r m a n  and D e a n s , 2000) and volatile oils 
obtained from coniferous species such as Pinus den­
siflora and P. koraiensis in particular (H o n g  et al., 
2004). Systematic research has been conducted to 
correlate the effects of different chemical structures, 
functional groups, and stereochemistry associated 
with various antimicrobially active low-molecular-
weight terpenoids, and it seems that a certain degree 
of structure-activity correlation exists (D o r m a n 
and D e a n s , 2000). It is of particular interest to 
note that D o r m a n  and D e a n s  (2000) established 
that α–pinene is antibacterially inactive relative to 
its isomer β–pinene when tested in vitro against 
25 genera of Gram-positive and Gram-negative 
bacteria. α–pinene is a monoterpene usually pres-
ent in most essential oils (S o k o v i ć  et al., 2000; 
K n e ž e v i ć - Vu k č e v i ć  et al., 2005). However, 
the present result indicates that α–pinene has high 
selective toxicity against the three tested strains of 
A. madura. This enables us to speculate about the 
possible mechanism of α–pinene action on the given 
microorganism in light of the fact that the bacte-
rial metabolism of α–pinene, which usually involves 
oxidation to its respective α–pinene oxide followed 
by conversion of the latter to acyclic metabolites, has 
been demonstrated in Nocardia (G r i f f i t h s et al.,   
1987), a genus very closely related to       Actinomadura. 
Further studies are required in order to gain an 
insight into the metabolic fate of α–pinene in A. 
madura. 
The established high selective toxicity of α-
pinene towards A. madura strains provides com-
pelling evidence of its efficacy in vitro. In vivo and 
possibly clinical studies are unquestionably needed 
to substantiate these findings. 
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Осетљивост три клинич­ка изолата Actinoma­
dura madurae, најч­ешћег изазивач­а актиномице-
томе, тестирана је in vitro на терпентинско уље 
добијено из смоле Pinus pinaster. Минималне 
инхибиторне концентрације (МИК) уља биле су 
100.3 - 124.8 µL/mL, а минималне микробицидал-
не концентрације (ММК) 100.3 - 150.0 µL/mL. 
α-пинен је показао снажну биоактивност, са вред-
ностима МИК 3.3 - 5.0 µL/mL, док је MMК изно-
сила 10.0 µL/m. Терпентинско уље Pinus pinaster 
и α-пинен могу бити корисни агенси у третману 
мицетоме изазване таксоном A. madurae.
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